International Stem Cell CORP
ISCO· OTC
Released Nov 13, 2014, before the open
10-Q filed Nov 13, 2014, 44 days after period end · 0001564590-14-005595
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $1.96M | $1.67M | $1.19M | $842.00K |
| Net Income | -$2.03M | -$3.80M | -$2.08M | -$2.57M |
| EPS Diluted |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$1.40 |
| -$0.03 |
| -$0.02 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.